OTRK

OTRK

USD

Ontrak Inc. Common Stock

$1.490+0.000 (0.000%)

Reaalajas hind

Healthcare
Health Information Services
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$1.490

Kõrge

$1.500

Madal

$1.410

Maht

0.00M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

6.3M

Tööstusharu

Health Information Services

Riik

United States

Kauplemisstatistika

Keskmine maht

0.02M

Börs

NCM

Valuuta

USD

52 nädala vahemik

Madal $1.27Praegune $1.490Kõrge $5.53

Tehisintellekti analüüsiaruanne

Viimati uuendatud: 20. apr 2025
Tehisintellekti loodudAndmeallikas: Yahoo Finance, Bloomberg, SEC

[OTRK: Ontrak Inc. Common Stock]: Navigating Mixed Signals - What's Next?

Stock Symbol: OTRK Generate Date: 2025-04-20 15:14:38

Let's take a look at Ontrak (OTRK), a company in the health tech space, and try to make sense of what's going on with its stock. We've got some recent news, price history, and even what an AI thinks might happen. No fancy jargon here, just straight talk.

Recent News Buzz - A Bit of a Mixed Bag

So, what's the vibe around Ontrak lately? It's not all sunshine and roses, but there's a glimmer of good news mixed in.

The company just dropped its financial report for the end of last year, and honestly, it's not great. Revenue is down – both for the last quarter and the whole year. They're also operating at a loss, though they managed to cut those losses a bit compared to the year before. Think of it like this: they're selling less stuff and still spending more than they're bringing in, even if they're trying to tighten their belts a little. That's the downbeat part.

However, it's not all bad news. Ontrak also announced they've gotten the green light to operate as a Medicaid provider in two more states. This is actually pretty positive. Medicaid is a big government healthcare program, so getting approved in new states means they can reach more people and potentially grow their business in the future. Think of it as opening up new markets for their services.

Bottom line on news: The recent financial results are a definite worry, showing the company is struggling with revenue. But, the Medicaid expansion is a bright spot, suggesting they are still finding ways to grow their reach. It's a mixed picture, not clearly positive or negative.

Price Check - What's the Stock Been Up To?

Now, let's peek at the stock price. Over the last month or so, it's been a bit of a rollercoaster, but mostly trending downwards. If you look back at the chart, you'll see it started around $1.80 back in late January, and lately, it's been bouncing around the $1.40-$1.50 range. There was a bit of a jump upwards in late March, and again more recently, but it didn't really stick. It feels like the stock is trying to find a bottom, but it's been a bumpy ride.

Right now, the stock is around $1.42 (based on the last data point we have). Interestingly, an AI prediction model thinks the price might nudge up a little bit in the next couple of days – nothing huge, just a small percentage increase.

Price Trend Summary: Downward trend overall recently, with some volatility. Current price is low in the recent range. AI sees a slight potential for a short-term bump.

Outlook & Strategy Ideas - Putting It All Together

So, what does this all mean for someone looking at Ontrak stock? It's tricky because we have these conflicting signals.

On one hand, the bad financial results are a red flag. Companies losing money and with shrinking revenue are generally riskier. This might make some investors hesitant.

On the other hand, the Medicaid expansion is a real positive, and the stock price is already quite low – near its 52-week low, in fact. Plus, the AI prediction, while not a guarantee, hints at a possible short-term upward move. And, digging into some analyst recommendations (from the data provided), they see "bullish momentum" and call it an "undervalued gem," pointing to a potential "news-driven surge." They even suggest a technical breakout signal. However, they also acknowledge some fundamental weaknesses like negative growth and high debt. It's a real mix of opinions!

Possible Lean: Given the low price, the slightly positive AI prediction, and the Medicaid news, there might be a short-term opportunity for a cautious buy. However, the financial losses are a serious concern, so this is definitely not a slam dunk.

Potential Entry Consideration: If you were thinking about dipping your toes in, maybe consider looking for an entry point around the current price level, say in the $1.40-$1.45 range. This area seems to have acted as some support recently.

Potential Exit/Stop-Loss Consideration: To manage risk, a stop-loss is crucial. Perhaps placing a stop-loss order a bit below the recent lows, maybe around $1.27 (as suggested in the recommendation data), could be a way to limit potential losses if the stock keeps falling. For taking profits, if the stock does bounce, levels around $1.70-$1.75 (previous resistance areas) could be potential targets. But remember, these are just potential levels, not guarantees.

Important Note: This is a small company in the health information services sector. They are trying to use AI and telehealth, which are hot areas, but they are also facing financial challenges. Keep in mind their small market cap and lower trading volume – this stock can be more volatile than larger, more established companies.

In short: Ontrak is a bit of a gamble right now. There are reasons to be cautious (financial losses), but also some potential upside (Medicaid growth, low price, short-term AI prediction). Any investment here would need to be carefully considered and managed with risk controls in place.


Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. The stock market is inherently risky, and prices can go down as well as up. Investors should conduct their own thorough research and/or consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results.

Seotud uudised

BusinessWire

Ontrak Health Announces 2024 Fourth Quarter and Year End Financial Results

Q4 revenue of $3.1 million, down 11% year over year; and full year revenue of $10.8 million, down 15% year over year Q4 operating loss of $(4.4) million, a 16% decrease year over year; full year operating loss of

Vaata rohkem
Ontrak Health Announces 2024 Fourth Quarter and Year End Financial Results
BusinessWire

Ontrak Health to Report 2024 Fourth Quarter Financial Results on April 14, 2025

Ontrak Health (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced it will report financial results for the fourth quarter 2024 on Monday, April 14,

Vaata rohkem
Ontrak Health to Report 2024 Fourth Quarter Financial Results on April 14, 2025
BusinessWire

Ontrak Secures Medicaid Provider Designation in Two New States, Enhancing Direct Service Delivery Capabilities

Ontrak, Inc (NASDAQ:OTRK), a leading AI-powered and telehealth-enabled behavioral healthcare company today announced that a new affiliated practice association has secured official Medicaid designation in two new

Vaata rohkem
Ontrak Secures Medicaid Provider Designation in Two New States, Enhancing Direct Service Delivery Capabilities

Tehisintellekti ennustusBeta

Tehisintellekti soovitus

Tõusev

Uuendatud kell: 4. mai 2025, 19:20

LangevNeutraalneTõusev

59.9% Kindlus

Risk ja kauplemine

Riskitase4/5
Kõrge risk
Sobib
VäärtusAgressiivne
Kauplemisjuhend

Sisenemispunkt

$1.44

Võta kasum

$1.65

Peata kahjum

$1.34

Põhitegurid

PDI 32.0 on MDI 24.1 kohal ADX-iga 9.0, mis viitab tõusutrendile
Kauplemismaht on 1.5x keskmisest (1,069), mis viitab suurenenud turuosalusele
MACD 0.0109 on signaalijoone 0.0088 kohal, mis viitab tõusvale ristumisele

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.